Fujian Wanchen Biotechnology Co. Ltd
Fujian Wanchen Food Group Co., Ltd., together with its subsidiaries, engages in the research, development, cultivation, production, and sale of edible fungi in China and internationally. The company provides enoki and golden enoki, white jade, crab, seafood, deer antler, oyster, and other mushrooms products, as well as flammulina velutipes, hydrangea edulis, and pleurotus eryngii. It is also invo… Read more
Market Cap & Net Worth: Fujian Wanchen Biotechnology Co. Ltd (300972)
Fujian Wanchen Biotechnology Co. Ltd (SHE:300972) has a market capitalization of $5.23 Billion (CN¥38.35 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #4600 globally and #503 in its home market, demonstrating a -0.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fujian Wanchen Biotechnology Co. Ltd's stock price CN¥200.50 by its total outstanding shares 191293385 (191.29 Million).
Fujian Wanchen Biotechnology Co. Ltd Market Cap History: 2021 to 2026
Fujian Wanchen Biotechnology Co. Ltd's market capitalization history from 2021 to 2026. Data shows growth from $406.60 Million to $5.23 Billion (50.60% CAGR).
Fujian Wanchen Biotechnology Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fujian Wanchen Biotechnology Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Fujian Wanchen Biotechnology Co. Ltd's market cap is 0.06 times its annual revenue
0.16x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
7.14x
Fujian Wanchen Biotechnology Co. Ltd's market cap is 7.14 times its annual earnings
7.55x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $406.60 Million | $434.70 Million | $23.45 Million | 0.94x | 17.34x |
| 2022 | $313.90 Million | $549.26 Million | $47.74 Million | 0.57x | 6.58x |
| 2023 | $978.73 Million | $9.29 Billion | -$82.93 Million | 0.11x | N/A |
| 2024 | $2.10 Billion | $32.33 Billion | $293.52 Million | 0.06x | 7.14x |
Competitor Companies of 300972 by Market Capitalization
Companies near Fujian Wanchen Biotechnology Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Fujian Wanchen Biotechnology Co. Ltd by market ranking:
- Archer-Daniels-Midland Company (NYSE:ADM): Ranked #619 globally with a market cap of $33.40 Billion USD.
- Bunge Limited (NYSE:BG): Ranked #996 globally with a market cap of $19.69 Billion USD.
- Tyson Foods Inc (NYSE:TSN): Ranked #1128 globally with a market cap of $17.05 Billion USD.
- Muyuan Foodstuff Co Ltd (SHE:002714): Ranked #1198 globally with a market cap of $15.65 Billion USD ( CN¥114.85 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #619 | Archer-Daniels-Midland Company | NYSE:ADM | $33.40 Billion | $70.75 |
| #996 | Bunge Limited | NYSE:BG | $19.69 Billion | $123.62 |
| #1128 | Tyson Foods Inc | NYSE:TSN | $17.05 Billion | $61.83 |
| #1198 | Muyuan Foodstuff Co Ltd | SHE:002714 | $15.65 Billion | CN¥49.74 |
Fujian Wanchen Biotechnology Co. Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Fujian Wanchen Biotechnology Co. Ltd's market cap moved from $406.60 Million to $ 5.23 Billion, with a yearly change of 50.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥5.23 Billion | -0.28% |
| 2025 | CN¥5.24 Billion | +150.06% |
| 2024 | CN¥2.10 Billion | +114.20% |
| 2023 | CN¥978.73 Million | +211.79% |
| 2022 | CN¥313.90 Million | -22.80% |
| 2021 | CN¥406.60 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Fujian Wanchen Biotechnology Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.23 Billion USD |
| MoneyControl | $5.23 Billion USD |
| MarketWatch | $5.23 Billion USD |
| marketcap.company | $5.23 Billion USD |
| Reuters | $5.23 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.